Radiographic enlargement of mandibular canal as first feature of non-Hodgkin's lymphoma

被引:18
作者
Buric, N. [1 ]
Jovanovic, G.
Radovanovic, Z. [2 ]
Buric, M. [3 ]
Tijanic, M.
机构
[1] Univ Nis, Clin Stomatol, Dept Oral & Maxillofacial Surg, Sch Med & Stomatol, Nish 18000, Serbia
[2] Ctr Clin, Inst Radiol, Nish, Serbia
[3] Univ Nis, Sch Med & Stomatol, Dept Orthodont, Nish 18000, Serbia
关键词
non-Hodgkin's lymphoma; mandible; neoplasm; panoramic radiography;
D O I
10.1259/dmfr/16059055
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Non-Hodgkin's lymphoma has the propensity to affect non-lymphoid tissue including oral tissue. Primary non-Hodgkin's lymphoma of the mandible mistreated as chronic periodontitis with diffuse enlargement of the mandibular canal and ice-cold numbness is very rarely described in English medical literature. A 57-year-old patient presented with a painful swelling on the left side of the mandible with a clinically chronic periodontitis associated with ice-cold numbness. A panoramic radiograph showed a diffuse uniform enlargement of the mandibular canal. Histological examination showed that the lesion was a primary intraosseous non-Hodgkin's lymphoma of the mandible. Immunohistochemical examination showed a positive reaction for CD20+, Ki-67+. Seven months after chemotherapy the patient was observed for possible life-threatening propagation of the disease. In conclusion, primary (extra-nodal) non-Hodgkin's lymphoma of the mandible usually clinically presents with bone swelling, teeth mobility and neurological disturbance. Radiographic features presenting as diffuse enlargement of the mandibular canal could be considered as non-Hodgkin's lymphoma. Dentomaxillofacial Radiology (2010) 39, 383-388. doi: 10.1259/dmfr/16059055
引用
收藏
页码:383 / 388
页数:6
相关论文
共 50 条
  • [41] Palliative chemotherapy in non-Hodgkin's lymphoma
    Salminen, E
    Nikkanen, V
    Lindholm, L
    ONCOLOGY, 1997, 54 (02) : 108 - 111
  • [42] Rituximab in the treatment of non-Hodgkin's lymphoma
    Hauptrock, Beate
    Hess, Georg
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04) : 619 - 633
  • [43] Primary pulmonary non-Hodgkin's lymphoma
    Kim, JH
    Lee, SH
    Park, J
    Kim, HY
    Lee, SI
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    Han, JH
    Ko, YH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) : 510 - 514
  • [44] Epidemiology of Non-Hodgkin's Lymphoma in India
    Nair, Reena
    Arora, Neeraj
    Mallath, Mohandas K.
    ONCOLOGY, 2016, 91 : 18 - 25
  • [45] Ruxolitinib and risk of non-Hodgkin's lymphoma
    Bergeron, S.
    Bene, J.
    Wemeau, M.
    Pinel, S.
    Guihard, C.
    Peyrouzet, H.
    Gautier, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 64 - 65
  • [46] Antiangiogenic Therapies in Non-Hodgkin's Lymphoma
    Ruan, J.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (09) : 1030 - 1043
  • [47] The significance of autoantibodies in non-Hodgkin's lymphoma
    Timuragaoglu, A
    Duman, A
    Öngut, G
    Saka, O
    Karadogan, I
    LEUKEMIA & LYMPHOMA, 2000, 40 (1-2) : 119 - 122
  • [48] Whipple's disease and Non-Hodgkin's lymphoma
    Gruner, U
    Goesch, P
    Donner, A
    Peters, U
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (04): : 305 - 309
  • [49] Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma
    R E Lerner
    L J Burns
    Bone Marrow Transplantation, 2003, 31 : 531 - 537
  • [50] Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma
    Lerner, RE
    Burns, LJ
    BONE MARROW TRANSPLANTATION, 2003, 31 (07) : 531 - 537